Viewing Study NCT04239833


Ignite Creation Date: 2025-12-25 @ 2:46 AM
Ignite Modification Date: 2025-12-31 @ 2:10 PM
Study NCT ID: NCT04239833
Status: UNKNOWN
Last Update Posted: 2020-01-27
First Post: 2020-01-02
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of SH-1028 Tablets Versus Gefitinib in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer
Sponsor: Nanjing Sanhome Pharmaceutical, Co., Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module